ProfileGDS4177 / 214265_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 16% 17% 20% 18% 80% 57% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated9.7316
GSM603099KU-812 non-treated9.8217
GSM603098KCL-22 Imatinib-treated10.3420
GSM603097KCL-22 non-treated10.0318
GSM603102JURL-MK1 Imatinib-treated204.3280
GSM603101JURL-MK1 non-treated45.0357